髓系来源抑制性细胞异质性及其亚群定义。
Myeloid-derived suppressor cell heterogeneity and subset definition.
机构信息
Department of Oncology and Surgical Sciences, University of Padua, Padua, Italy.
出版信息
Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17.
Myeloid derived suppressor cells (MDSCs) are defined in mice on the basis of CD11b and Gr-1 marker expression and the functional ability to inhibit T lymphocyte activation. Nevertheless the term 'heterogeneous' remains the first, informal feature commonly attributed to this population. It is clear that CD11b(+)Gr-1(+) cells are part of a myeloid macropopulation, which comprises at least two subsets of polymorphonuclear and monocytic cells with different immunosuppressive properties. While recent literature shows substantial agreement on the immunoregulatory property of the monocytic MDSC subset, there is still contrasting evidence on the role of the granulocytic fraction. Moreover, this dichotomy holds true for human MDSCs. We attempt here to summarize conflicting findings in the field and provide some possible, unifying explanations.
髓系来源的抑制细胞(MDSCs)在小鼠中根据 CD11b 和 Gr-1 标志物表达和抑制 T 淋巴细胞活化的功能能力来定义。然而,“异质性”一词仍然是第一个通常归因于该群体的非正式特征。很明显,CD11b(+)Gr-1(+)细胞是髓样大群体的一部分,该群体至少包括两种具有不同免疫抑制特性的多形核细胞和单核细胞亚群。尽管最近的文献表明单核 MDSC 亚群具有实质性的免疫调节特性,但关于粒细胞部分的作用仍存在相互矛盾的证据。此外,这种二分法对人类 MDSCs 也适用。我们在这里尝试总结该领域的矛盾发现,并提供一些可能的统一解释。